BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Quercetin
,
rs6983267
,
FGF21
,
glucose metabolic process
,
Stem cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lung squamous cell carcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
Cancer stem cells isolated from lung cancer A549 and NCI-H2170 cell lines
Non-small-cell lung cancer cell lines A549 and NCI-H157 response to SN1 methylating-agents treatment
Squamous cell carcinoma of lung H520 cells with FGGY loss and treated with ML355 and NVR
Lung squamous cell carcinoma NCI-H1703 cells grown attached or floating with SPIB knockdown
Profiling of NSCLC patients for predicting recurrence free survival
Explore Curated Studies Results
Literature
Most Relevant Literature
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC.
Prediction of immune subtypes and overall survival in lung squamous cell carcinoma.
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.
Identification of novel biomarkers for lung squamous cell carcinoma.
Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamou…
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcino…
Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ